Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 30, 2004 Filed Feb 2, 2004 19:18 UTC |
STEERE WILLIAM C JRDirector
|
Tax withholdingCommon Stock | 29,945 | $36.44 | $1,091,195.80 |
DisclosureSEC source: 0000078003-04-000023 · ste565.xml · nonDerivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,972,339 Read SEC document |
| January 02, 2004 Filed Jan 5, 2004 20:43 UTC |
KINDLER JEFFREY BSenior Vice President
|
Tax withholdingCommon Stock | 1,541 | $35.21 | $54,258.61 |
DisclosureSEC source: 0000078003-04-000012 · kin563.xml · nonDerivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,382 Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 16:44 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 58 | $35.33 | $2,049.14 |
DisclosureSEC source: 0000078003-04-000001 · can543.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Common Stock · 58 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 16:44 UTC |
CORR PETER BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 42 | $35.33 | $1,483.86 |
DisclosureSEC source: 0000078003-04-000002 · cor544.xml · derivative · entry 1 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 845 Underlying: Common Stock · 42 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 16:44 UTC |
HARDWICK CHARLES LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 26 | $35.33 | $918.58 |
DisclosureSEC source: 0000078003-04-000003 · har545.xml · derivative · entry 1 HARDWICK CHARLES L · CIK 0001176311 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,677 Underlying: Common Stock · 26 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 16:44 UTC |
JACKSON YVONNE RSenior VP - Human Resources
|
GrantPhantom Stock Units SSP · Derivative | 28 | $35.33 | $989.24 |
DisclosureSEC source: 0000078003-04-000004 · jac546.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177 Underlying: Common Stock · 28 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 16:44 UTC |
KATEN KAREN LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 58 | $35.33 | $2,049.14 |
DisclosureSEC source: 0000078003-04-000005 · kat547.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,372 Underlying: Common Stock · 58 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 16:44 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 108 | $35.33 | $3,815.64 |
DisclosureSEC source: 0000078003-04-000006 · mck548.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,701 Underlying: Common Stock · 108 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 16:44 UTC |
MITCHELL JOHN WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 155 | $35.33 | $5,476.15 |
DisclosureSEC source: 0000078003-04-000007 · mit549.xml · derivative · entry 1 MITCHELL JOHN W · CIK 0001174455 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,569 Underlying: Common Stock · 155 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 16:44 UTC |
NORTON ROBERT WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 35 | $35.33 | $1,236.55 |
DisclosureSEC source: 0000078003-04-000008 · nor550.xml · derivative · entry 1 NORTON ROBERT W · CIK 0001174457 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,923 Underlying: Common Stock · 35 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 16:44 UTC |
SHEDLARZ DAVID LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 209 | $35.33 | $7,383.97 |
DisclosureSEC source: 0000078003-04-000009 · she551.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,485 Underlying: Common Stock · 209 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 20:43 UTC |
CORNWELL W DONDirector
|
GrantPhantom Stock Units · Derivative | 442 | $35.33 | $15,615.86 |
DisclosureSEC source: 0000078003-04-000010 · cor553.xml · derivative · entry 1 CORNWELL W DON · CIK 0001174477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,847 Underlying: Common Stock · 442 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 20:43 UTC |
HOWELL WILLIAM RDirector
|
GrantPhantom Stock Units · Derivative | 737 | $35.33 | $26,038.21 |
DisclosureSEC source: 0000078003-04-000011 · how554.xml · derivative · entry 1 HOWELL WILLIAM R · CIK 0001174480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,278 Underlying: Common Stock · 737 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 20:43 UTC |
KINDLER JEFFREY BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 44 | $35.33 | $1,554.52 |
DisclosureSEC source: 0000078003-04-000012 · kin563.xml · derivative · entry 3 KINDLER JEFFREY B · CIK 0001174454 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,984 Underlying: Common Stock · 44 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 20:43 UTC |
LORCH GEORGE ADirector
|
GrantPhantom Stock Units · Derivative | 740 | $35.33 | $26,144.20 |
DisclosureSEC source: 0000078003-04-000013 · lor555.xml · derivative · entry 1 LORCH GEORGE A · CIK 0001174481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,795 Underlying: Common Stock · 740 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 20:43 UTC |
MEAD DANA GDirector
|
GrantPhantom Stock Units · Derivative | 649 | $35.33 | $22,929.17 |
DisclosureSEC source: 0000078003-04-000014 · mea556.xml · derivative · entry 1 MEAD DANA G · CIK 0001174482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,948 Underlying: Common Stock · 649 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 20:43 UTC |
RAINES FRANKLIN DDirector
|
GrantPhantom Stock Units · Derivative | 774 | $35.33 | $27,345.42 |
DisclosureSEC source: 0000078003-04-000015 · rai557.xml · derivative · entry 1 RAINES FRANKLIN D · CIK 0001174483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,048 Underlying: Common Stock · 774 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 20:43 UTC |
SIMMONS RUTH JDirector
|
GrantPhantom Stock Units · Derivative | 612 | $35.33 | $21,621.96 |
DisclosureSEC source: 0000078003-04-000016 · sim558.xml · derivative · entry 1 SIMMONS RUTH J · CIK 0001174484 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,107 Underlying: Common Stock · 612 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 20:43 UTC |
STEERE WILLIAM C JRDirector
|
OtherPhantom Stock Units SSP · Derivative | 20,541 | $35.33 | $725,713.53 |
DisclosureSEC source: 0000078003-04-000017 · ste559.xml · derivative · entry 2 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,834 Underlying: Common Stock · 20,541 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 20:43 UTC |
STEERE WILLIAM C JRDirector
|
GrantPhantom Stock Units · Derivative | 365 | $35.33 | $12,895.45 |
DisclosureSEC source: 0000078003-04-000017 · ste559.xml · derivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,650 Underlying: Common Stock · 365 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 20:43 UTC |
VALLES JEAN PAULDirector
|
GrantPhantom Stock Units · Derivative | 948 | $35.33 | $33,492.84 |
DisclosureSEC source: 0000078003-04-000018 · val560.xml · derivative · entry 1 VALLES JEAN PAUL · CIK 0001033869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,329 Underlying: Common Stock · 948 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 15, 2003 Filed Dec 16, 2003 18:49 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 60 | $34.44 | $2,066.40 |
DisclosureSEC source: 0000078003-03-000308 · can533.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,455 Underlying: Common Stock · 60 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 15, 2003 Filed Dec 16, 2003 18:49 UTC |
CORR PETER BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 44 | $34.44 | $1,515.36 |
DisclosureSEC source: 0000078003-03-000309 · cor534.xml · derivative · entry 1 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 803 Underlying: Common Stock · 44 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 15, 2003 Filed Dec 16, 2003 18:49 UTC |
HARDWICK CHARLES LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 27 | $34.44 | $929.88 |
DisclosureSEC source: 0000078003-03-000310 · har535.xml · derivative · entry 3 HARDWICK CHARLES L · CIK 0001176311 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,651 Underlying: Common Stock · 27 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 15, 2003 Filed Dec 16, 2003 18:49 UTC |
HARDWICK CHARLES LSenior Vice President
|
GiftCommon Stock | 325 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-03-000310 · har535.xml · nonDerivative · entry 1 HARDWICK CHARLES L · CIK 0001176311 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,580 Read SEC document |
| December 15, 2003 Filed Dec 16, 2003 18:49 UTC |
KINDLER JEFFREY BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 45 | $34.44 | $1,549.80 |
DisclosureSEC source: 0000078003-03-000313 · kin538.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,940 Underlying: Common Stock · 45 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 15, 2003 Filed Dec 16, 2003 18:49 UTC |
JACKSON YVONNE RSenior VP - Human Resources
|
GrantPhantom Stock Units SSP · Derivative | 29 | $34.44 | $998.76 |
DisclosureSEC source: 0000078003-03-000311 · jac536.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149 Underlying: Common Stock · 29 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 15, 2003 Filed Dec 16, 2003 18:49 UTC |
KATEN KAREN LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 62 | $34.44 | $2,135.28 |
DisclosureSEC source: 0000078003-03-000312 · kat537.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,314 Underlying: Common Stock · 62 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 15, 2003 Filed Dec 16, 2003 18:49 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 118 | $34.44 | $4,063.92 |
DisclosureSEC source: 0000078003-03-000314 · mck539.xml · derivative · entry 4 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,593 Underlying: Common Stock · 118 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 15, 2003 Filed Dec 16, 2003 18:49 UTC |
MITCHELL JOHN WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 152 | $34.44 | $5,234.88 |
DisclosureSEC source: 0000078003-03-000315 · mit540.xml · derivative · entry 1 MITCHELL JOHN W · CIK 0001174455 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,414 Underlying: Common Stock · 152 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 15, 2003 Filed Dec 16, 2003 18:49 UTC |
NORTON ROBERT WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 34 | $34.44 | $1,170.96 |
DisclosureSEC source: 0000078003-03-000316 · nor541.xml · derivative · entry 1 NORTON ROBERT W · CIK 0001174457 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,888 Underlying: Common Stock · 34 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 15, 2003 Filed Dec 16, 2003 18:49 UTC |
SHEDLARZ DAVID LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 212 | $34.44 | $7,301.28 |
DisclosureSEC source: 0000078003-03-000317 · she542.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,276 Underlying: Common Stock · 212 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 12, 2003 Filed Dec 16, 2003 18:49 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GiftCommon Stock | 2,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-03-000314 · mck539.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,097,198 Read SEC document |
| December 02, 2003 Filed Dec 3, 2003 16:57 UTC |
STEERE WILLIAM C JRDirector
|
GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-03-000307 · ste532.xml · nonDerivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,995,470 Read SEC document |
| December 01, 2003 Filed Dec 2, 2003 18:03 UTC |
SHEDLARZ DAVID LExecutive Vice President
|
SaleCommon Stock | 25,275 | $34.00 | $859,350.00 |
DisclosureSEC source: 0000078003-03-000305 · she531.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 451,748 Read SEC document |
| November 26, 2003 Filed Dec 1, 2003 18:25 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 61 | $33.83 | $2,063.63 |
DisclosureSEC source: 0000078003-03-000295 · can521.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,395 Underlying: Common Stock · 61 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 26, 2003 Filed Dec 1, 2003 18:25 UTC |
CORR PETER BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 45 | $33.83 | $1,522.35 |
DisclosureSEC source: 0000078003-03-000296 · cor522.xml · derivative · entry 1 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 759 Underlying: Common Stock · 45 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 26, 2003 Filed Dec 1, 2003 18:25 UTC |
HARDWICK CHARLES LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 27 | $33.83 | $913.41 |
DisclosureSEC source: 0000078003-03-000297 · har523.xml · derivative · entry 1 HARDWICK CHARLES L · CIK 0001176311 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,624 Underlying: Common Stock · 27 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 26, 2003 Filed Dec 1, 2003 18:25 UTC |
JACKSON YVONNE RSenior VP - Human Resources
|
GrantPhantom Stock Units SSP · Derivative | 29 | $33.83 | $981.07 |
DisclosureSEC source: 0000078003-03-000298 · jac524.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120 Underlying: Common Stock · 29 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 26, 2003 Filed Dec 1, 2003 18:25 UTC |
KATEN KAREN LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 61 | $33.83 | $2,063.63 |
DisclosureSEC source: 0000078003-03-000299 · kat525.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,252 Underlying: Common Stock · 61 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 26, 2003 Filed Dec 1, 2003 18:25 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 116 | $33.83 | $3,924.28 |
DisclosureSEC source: 0000078003-03-000301 · mck527.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,475 Underlying: Common Stock · 116 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 26, 2003 Filed Dec 1, 2003 18:25 UTC |
KINDLER JEFFREY BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 46 | $33.83 | $1,556.18 |
DisclosureSEC source: 0000078003-03-000300 · kin526.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,895 Underlying: Common Stock · 46 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 26, 2003 Filed Dec 1, 2003 18:26 UTC |
MITCHELL JOHN WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 164 | $33.83 | $5,548.12 |
DisclosureSEC source: 0000078003-03-000302 · mit528.xml · derivative · entry 1 MITCHELL JOHN W · CIK 0001174455 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,262 Underlying: Common Stock · 164 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 26, 2003 Filed Dec 1, 2003 18:26 UTC |
NORTON ROBERT WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 38 | $33.83 | $1,285.54 |
DisclosureSEC source: 0000078003-03-000303 · nor529.xml · derivative · entry 1 NORTON ROBERT W · CIK 0001174457 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,854 Underlying: Common Stock · 38 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 26, 2003 Filed Dec 1, 2003 18:26 UTC |
SHEDLARZ DAVID LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 219 | $33.83 | $7,408.77 |
DisclosureSEC source: 0000078003-03-000304 · she530.xml · derivative · entry 4 SHEDLARZ DAVID L · CIK 0001174459 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,064 Underlying: Common Stock · 219 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 26, 2003 Filed Dec 1, 2003 18:26 UTC |
SHEDLARZ DAVID LExecutive Vice President
|
SaleCommon Stock | 25,000 | $33.95 | $848,750.00 |
DisclosureSEC source: 0000078003-03-000304 · she530.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,023 Read SEC document |
| November 20, 2003 Filed Nov 24, 2003 16:01 UTC |
KATEN KAREN LExecutive Vice President
|
GiftCommon Stock | 466 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-03-000294 · kat520.xml · nonDerivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 639,212 Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:40 UTC |
KATEN KAREN LExecutive Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 64,800 | $0.00 Strike: $8.17 | $0.00 |
DisclosureSEC source: 0000078003-03-000291 · kat517.xml · derivative · entry 4 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,800 shares Expires 2005-08-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in 5 equal annual installments beginning on August 24, 1996. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:40 UTC |
KATEN KAREN LExecutive Vice President
|
SaleCommon Stock | 64,800 | $34.37 | $2,227,176.00 |
DisclosureSEC source: 0000078003-03-000291 · kat517.xml · nonDerivative · entry 2 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 639,678 Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:40 UTC |
KATEN KAREN LExecutive Vice President
|
Exercise / conversionCommon Stock | 64,800 | $8.17 | $529,416.00 |
DisclosureSEC source: 0000078003-03-000291 · kat517.xml · nonDerivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 704,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.